Vote Scores

Home / Companies / Celltrion Pharm Inc. / 24 Mar 2026

Meeting · year to 30 June 202627 filers reporting

Celltrion Pharm Inc.: meeting of 24 Mar 2026

Votes reported on Form N-PX, item by item

27 Form N-PX filers reported votes at the Celltrion Pharm Inc. meeting of 24 Mar 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

1 nominee; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

39 vote records from 27 filers. 0 of the 27 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management27 filers
2

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

40 vote records from 25 filers. 0 of the 25 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management25 filers100.0% for0.0% against0.0% against management820,650 reported shares, counted once per item in this group
3

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

153 vote records from 27 filers. 0 of the 27 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management27 filers100.0% for0.0% against0.0% against management3,147,202 reported shares, counted once per item in this group
4

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

56 vote records from 27 filers. 0 of the 27 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management27 filers100.0% for0.0% against0.0% against management1,189,274 reported shares, counted once per item in this group
5

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

102 vote records from 23 filers. 0 of the 23 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management23 filers100.0% for0.0% against0.0% against management2,078,298 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
American CenturyFor
Franklin TempletonFor
Charles SchwabFor
Nuveen and TIAAFor
Morgan Stanley, Eaton Vance and CalvertFor
Goldman SachsFor
Northern Trust and FlexSharesFor
BNY MellonFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Celltrion Pharm Inc. meeting?

27 Form N-PX filers reported votes at the meeting of 24 Mar 2026. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Celltrion Pharm Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Celltrion Pharm Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Celltrion Pharm Inc. with a meeting date within three days of 24 Mar 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.